FDA inspection
Guangzhou PharmaLab Co., Ltd.: FDA inspection ending Aug 30, 2023
FDA inspection 1217730 · Official Action Indicated (OAI) · Guangzhou
Key facts
| Inspection ID | 1217730 |
|---|---|
| Firm | Guangzhou PharmaLab Co., Ltd. |
| FEI number | 3015545246 |
| Address | Building 3 6th Floor, No. 12 Ruifa Road; Huangpu District |
| City | Guangzhou |
| Fiscal year | 2023 |
| Inspection end date | Aug 30, 2023 |
| Classification | Official Action Indicated (OAI) |
| Project area | Generic Drug Evaluation |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data